Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer

Brauch, Hiltrud; Schwab, Matthias

dc.contributor.author	Brauch, Hiltrud	de_DE
dc.contributor.author	Schwab, Matthias	de_DE
dc.date.accessioned	2014-09-08T14:39:43Z
dc.date.available	2014-09-08T14:39:43Z
dc.date.issued	2014	de_DE
dc.identifier.issn	0306-5251	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/56076
dc.language.iso	en	de_DE
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/bcp.12229	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140610213910_00309	de_DE
utue.publikation.seiten	695-703	de_DE
utue.personen.roh	Brauch, Hiltrud	de_DE
utue.personen.roh	Schwab, Matthias	de_DE
dcterms.isPartOf.ZSTitelID	British Journal of Clinical Pharmacology	de_DE
dcterms.isPartOf.ZS-Issue	SI	de_DE
dcterms.isPartOf.ZS-Volume	77	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE